Although all head and neck cancer patients show a slight correlation between increased ERα or ERβ expression and improved survival odds, this trend is not mirrored in laryngeal cancer, where ERα is the predominant determinate of ER-associated survival. The gene discussed is ESR2; the disease is laryngeal carcinoma.